Ramona Doyle
Chief Executive Officer bij The MAVEN Project
Profiel
Op dit moment is Ramona Doyle Chief Medical Officer van Recursion Pharmaceuticals, Inc.
Actieve functies van Ramona Doyle
| Bedrijven | Functie | Begin |
|---|---|---|
| The MAVEN Project | Chief Executive Officer | 01-09-2020 |
| The University of California, San Francisco | Corporate Officer/Principal | 01-10-2011 |
Eerdere bekende functies van Ramona Doyle
| Bedrijven | Functie | Einde |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 07-06-2022 |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01-05-2018 |
| California Institute for Regenerative Medicine | Corporate Officer/Principal | 01-07-2016 |
| Stanford University School of Medicine | Corporate Officer/Principal | 01-01-2008 |
Opleiding van Ramona Doyle
| University of Oxford | Graduate Degree |
| Sewanee-The University of the South | Undergraduate Degree |
| Emory University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| California Institute for Regenerative Medicine | Government |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Commercial Services |
| The MAVEN Project |
